Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Unbiased RNAi screen for hepcidin regulators links hepcidin suppression to proliferative Ras/RAF and nutrient-dependent mTOR signaling

Katarzyna Mleczko-Sanecka, Franziska Roche, Ana Rita da Silva, Debora Call, Flavia D’Alessio, Anan Ragab, Philip E. Lapinski, Ramesh Ummanni, Ulrike Korf, Christopher Oakes, Georg Damm, Lorenza A. D’Alessandro, Ursula Klingmüller, Philip D. King, Michael Boutros, Matthias W. Hentze, Martina U. Muckenthaler

Blood (2014) 123 (10): 1574–1585.

https://doi.org/10.1182/blood-2013-07-515957

Published: 2014

Includes: Supplemental data

Journal Articles

The histone methyltransferase Ezh2 is a crucial epigenetic regulator of allogeneic T-cell responses mediating graft-versus-host disease

Shan He, Fang Xie, Yongnian Liu, Qing Tong, Kazuhiro Mochizuki, Philip E. Lapinski, Ram-Shankar Mani, Pavan Reddy, Izumi Mochizuki, Arul M. Chinnaiyan, Shin Mineishi, Philip D. King, Yi Zhang

Blood (2013) 122 (25): 4119–4128.

https://doi.org/10.1182/blood-2013-05-505180

Published: 2013

Includes: Supplemental data

Journal Articles

The Histone Methyltransferase Ezh2 Is a Crucial Epigenetic Regulator Of Allogeneic T Cell Responses and Graft-Versus-Host Disease In Mice

Shan He, PhD, Fang Xie, Yongnian Liu, MS, Qing Tong, MS, Kazuhiro Mochizuki, MD, PhD, Philip E Lapinski, PhD, Pavan Reddy, MD, Izumi Mochizuki, MD, Arul M. Chinnaiyan, MD, PhD, Shin Mineishi, MD, Philip D King, PhD, Yi Zhang, MD, PhD

Blood (2013) 122 (21): 137.

https://doi.org/10.1182/blood.V122.21.137.137

Published: 2013

Journal Articles

Notch Inhibition in Alloreactive CD4 + and CD8 + T Cells Blocks Graft-Versus-Host Disease by Inducing a Hyporesponsive Program with Features of T Cell Anergy

Ashley R Sandy, BS, Jooho Chung, BS, Ivy T Tran, BS, Gloria T Shan, BS, Ann Friedman, BS, Timothy S Blackwell, MD-PhD, Pavan Reddy, M.D., Philip D King, PhD, Ivan Maillard, MD, PhD

Blood (2012) 120 (21): 340.

https://doi.org/10.1182/blood.V120.21.340.340

Published: 2012

Journal Articles

Histone Methyltransferase Ezh2 Controls T-Cell Immunity by Regulating Bioenergetic Metabolism

Shan He, PhD, Fang Xie, MD, Qing Tong, MS, Kazuhiro Mochizuki, MD, PhD, Yongnian Liu, MS, Philip E Lapinski, PhD, Shin Mineishi, Ram Shankar Mani, MD, Victor E Marquez, Arul M. Chinnaiyan, MD, PhD, Philip D King, PhD, Yi Zhang, MD, PhD

Blood (2012) 120 (21): 953.

https://doi.org/10.1182/blood.V120.21.953.953

Published: 2012

NARROW

Unbiased RNAi screen for hepcidin regulators links hepcidin suppression to proliferative Ras/RAF and nutrient-dependent mTOR signaling

The histone methyltransferase Ezh2 is a crucial epigenetic regulator of allogeneic T-cell responses mediating graft-versus-host disease

The Histone Methyltransferase Ezh2 Is a Crucial Epigenetic Regulator Of Allogeneic T Cell Responses and Graft-Versus-Host Disease In Mice

Notch Inhibition in Alloreactive CD4 + and CD8 + T Cells Blocks Graft-Versus-Host Disease by Inducing a Hyporesponsive Program with Features of T Cell Anergy

Histone Methyltransferase Ezh2 Controls T-Cell Immunity by Regulating Bioenergetic Metabolism

Email alerts

ASH Publications

American Society of Hematology

Unbiased RNAi screen for hepcidin regulators links hepcidin suppression to proliferative Ras/RAF and nutrient-dependent mTOR signaling

The histone methyltransferase Ezh2 is a crucial epigenetic regulator of allogeneic T-cell responses mediating graft-versus-host disease

The Histone Methyltransferase Ezh2 Is a Crucial Epigenetic Regulator Of Allogeneic T Cell Responses and Graft-Versus-Host Disease In Mice

Notch Inhibition in Alloreactive CD4 + and CD8 + T Cells Blocks Graft-Versus-Host Disease by Inducing a Hyporesponsive Program with Features of T Cell Anergy

Histone Methyltransferase Ezh2 Controls T-Cell Immunity by Regulating Bioenergetic Metabolism

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only